See also this year's filing and all EDGAR filings for this company.
PDF Report 0001802665_2023_Harmony_Biosciences_Holdings_Inc.pdf
Logs
| info | Ambiguous roles for statement | input.sec.calculation_linkbase.expand_agg | {'statement': 'operations', 'valid_roles': {'00200 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)': 15, '00300 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) calc 2': 2}} |
Graph
Absolute values for 0001802665, Harmony Biosciences Holdings Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 400,285,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 160,953,000 |
| 2 | PropertyPlantAndEquipmentNet | 573,000 |
| 3 | remainder_Assets | 112,059,000 |
| 4 | LiabilitiesCurrent | 78,884,000 |
| 5 | LiabilitiesNoncurrent | 192,148,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 83,481,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 84,017,000 |
| 9 | ResearchAndDevelopmentExpense | 70,886,000 |
| 10 | remainder_Expenses | 2,503,000 |
| 11 | remainder_Revenues | 437,855,000 |
| 12 | remainder_NetIncome | -15,500,000 |
| 13 | remainder_ComprehensiveNetIncome | -151,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 673,870,000 |
| 1 | Liabilities | 271,032,000 |
| 2 | Expenses | 240,887,000 |
| 3 | Revenues | 437,855,000 |
| 4 | StockholdersEquity | 402,838,000 |
| 5 | NetIncome | 181,468,000 |
| 6 | ComprehensiveNetIncome | 181,392,500 |
| 7 | BaseVar | 819,647,500 |
| 8 | EconomicCapitalRatio | 1.85 |
Edgar->Model Mapping
Feature Distribution
Change over Time
